Shaping the Future of NMSC

Developer: MedLearning2017

Category: Education

4 installs

ratings

+3 weekly installs

trend steady

+3 monthly installs

trend steady

ASO Keyword Dashboard

Tracking 40 keywords for Shaping the Future of NMSC in Google Play

Developer: MedLearning2017 Category: education

Shaping the Future of NMSC tracks 40 keywords (no keywords rank yet; 40 need traction). Key metrics: opportunity 69.4, difficulty 44.8.

This program discusses the management of NMSC

Tracked keywords

0 ranked • 40 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

69.4

Top keyword: strong

Avg difficulty

44.8

Lower scores indicate easier wins

Opportunity leaders

strong

Opportunity: 73.0 • Difficulty: 48.4 • Rank —

Competitors: 1,215
68.3
managed

Opportunity: 72.0 • Difficulty: 43.5 • Rank —

Competitors: 385
62.7
skin

Opportunity: 72.0 • Difficulty: 48.8 • Rank —

Competitors: 949
63.7
due

Opportunity: 72.0 • Difficulty: 46.7 • Rank —

Competitors: 1,156
68.8
development

Opportunity: 72.0 • Difficulty: 45.8 • Rank —

Competitors: 1,011
70.4

Unranked opportunities

strong

Opportunity: 73.0 • Difficulty: 48.4 • Competitors: 1,215
managed

Opportunity: 72.0 • Difficulty: 43.5 • Competitors: 385
skin

Opportunity: 72.0 • Difficulty: 48.8 • Competitors: 949
due

Opportunity: 72.0 • Difficulty: 46.7 • Competitors: 1,156
development

Opportunity: 72.0 • Difficulty: 45.8 • Competitors: 1,011

High competition keywords

like

Total apps: 150,415 • Major competitors: 21,531

Latest rank: — • Difficulty: 68.5
offers

Total apps: 82,090 • Major competitors: 9,319

Latest rank: — • Difficulty: 60.3
including

Total apps: 66,643 • Major competitors: 8,693

Latest rank: — • Difficulty: 64.4
makes

Total apps: 50,396 • Major competitors: 5,481

Latest rank: — • Difficulty: 57.4
may

Total apps: 48,197 • Major competitors: 5,628

Latest rank: — • Difficulty: 69.2

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
place	69	100	57	78 37,575 competing apps Median installs: 32,284 Avg rating: 2.9	—	—	4,364 major competitor apps
enhance	69	100	55	77 30,373 competing apps Median installs: 33,880 Avg rating: 3.0	—	—	3,622 major competitor apps
management	69	100	52	77 32,852 competing apps Median installs: 18,996 Avg rating: 2.5	—	—	2,393 major competitor apps
program	71	100	47	73 19,009 competing apps Median installs: 26,294 Avg rating: 2.7	—	—	1,273 major competitor apps
including	67	100	64	82 66,643 competing apps Median installs: 40,188 Avg rating: 3.0	—	—	8,693 major competitor apps
managed	72	100	43	63 4,652 competing apps Median installs: 25,508 Avg rating: 2.9	—	—	385 major competitor apps
patient	71	100	38	61 3,718 competing apps Median installs: 18,204 Avg rating: 2.6	—	—	190 major competitor apps
improve	68	100	56	80 46,984 competing apps Median installs: 36,014 Avg rating: 2.9	—	—	5,304 major competitor apps
like	65	100	68	88 150,415 competing apps Median installs: 46,503 Avg rating: 3.0	—	—	21,531 major competitor apps
advanced	69	100	59	78 36,272 competing apps Median installs: 40,632 Avg rating: 3.0	—	—	4,727 major competitor apps
prior	71	100	44	62 3,973 competing apps Median installs: 31,947 Avg rating: 3.2	—	—	383 major competitor apps
skin	72	100	49	64 5,355 competing apps Median installs: 75,663 Avg rating: 3.0	—	—	949 major competitor apps
due	72	100	47	69 10,596 competing apps Median installs: 39,747 Avg rating: 2.8	—	—	1,156 major competitor apps
candidates	71	100	36	58 2,416 competing apps Median installs: 10,358 Avg rating: 1.7	—	—	73 major competitor apps
development	72	100	46	70 13,252 competing apps Median installs: 25,670 Avg rating: 2.6	—	—	1,011 major competitor apps
potential	72	100	48	69 10,688 competing apps Median installs: 27,318 Avg rating: 2.9	—	—	1,050 major competitor apps
response	71	100	39	61 3,785 competing apps Median installs: 24,115 Avg rating: 2.7	—	—	279 major competitor apps
may	68	100	69	80 48,197 competing apps Median installs: 37,379 Avg rating: 3.0	—	—	5,628 major competitor apps
cell	72	100	45	66 7,467 competing apps Median installs: 30,501 Avg rating: 2.6	—	—	859 major competitor apps
strong	73	100	48	68 9,880 competing apps Median installs: 39,752 Avg rating: 2.9	—	—	1,215 major competitor apps
investigation	69	100	33	50 802 competing apps Median installs: 38,884 Avg rating: 3.6	—	—	61 major competitor apps
approaches	69	100	32	48 662 competing apps Median installs: 20,104 Avg rating: 2.9	—	—	36 major competitor apps
alternative	71	100	47	62 4,234 competing apps Median installs: 28,122 Avg rating: 2.9	—	—	395 major competitor apps
offers	66	100	60	84 82,090 competing apps Median installs: 31,012 Avg rating: 2.8	—	—	9,319 major competitor apps
continued	70	100	36	55 1,650 competing apps Median installs: 26,134 Avg rating: 2.9	—	—	132 major competitor apps

App Description

This program discusses the management of NMSC

Non-melanoma skin cancers (NMSCs), including basal cell carcinoma and cutaneous squamous cell carcinoma, are typically managed with Mohs micrographic surgery, but advanced cases may require alternative approaches due to inoperability or progression. The immunogenicity of NMSCs makes them strong candidates for immune checkpoint inhibitor therapy, with agents like cemiplimab and pembrolizumab demonstrating favorable efficacy and tolerability. Emerging strategies, including neoadjuvant and intralesional immunotherapy, are under investigation to enhance tumor response prior to or in place of surgery. Continued development of these immunotherapeutic approaches offers the potential to improve outcomes in patient care.